Legal Opinion
Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
District Court, D. Delaware
Decided March 1, 2023No. 1:22-cv-00552Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE CIPLA USA, INC., ) Plaintiff, v. C.A. No. 22-552-GBW-SRF IPSEN BIOPHARMACEUTICALS, INC., Defendant. REPORT AND RECOMMENDATION Presently before the court in this civil action for violations of the Lanham Act, 15 U.S.C. § 1125(a), and related state law causes of action is the motion of defendant Ipsen Biopharmaceuticals, Inc. (“Ipsen”) to dismiss the complaint for lack of subject matter jurisdiction and failure to state a claim pursuant to Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6), respectively. (D.I. 16)! For the…
2Cases cited22 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Sandra Connelly v. Lane Construction CorpCourt of Appeals for the Third Circuit · 2016
17 more not listed; retrieve them via the Exa API.